Granules India completes US FDA cGMP audit at Chantilly site with procedural observationsGranules India completes US FDA cGMP audit at Chantilly site with procedural observations

Introduction

Leading pharmaceutical firm’s US subsidiary completed a routine cGMP audit at its Chantilly, Virginia facility, receiving four procedural observations and reporting no data integrity issues.

Also Read: Enviro Infra Engineers bags five major projects worth ₹1,481 Cr, read details here

Share price movement of Granules India

On April 06, 2026, Granules India Ltd opened at ₹602.10, down 1.95% from its previous close of ₹614.00. The stock reached a high of ₹638.00 (3.93%) and a low of ₹602.10 (-1.95%). By 2:59 PM, it traded at ₹637.55, a 3.84% increase, with a market cap of ₹15,471.34 crore.

Granules India Clears US FDA Audit

Granules India Limited’s subsidiary, Granules Pharmaceuticals, Inc., completed a routine US FDA cGMP audit at its Chantilly, Virginia site from March 30 to April 3, 2026. Four Form 483 observations were issued.

The observations relate to procedural matters only, with no data integrity issues reported. Granules India Limited will address the observations within stipulated timelines, maintaining compliance with quality, safety, and regulatory standards.

Stock performance of Granules India for period of 1 week, 6 months, and 1 year

Granules India Ltd delivered a 1-week return of -1.10%, a 6-month return of 11.8%, and a 1-year return of 34.3%.

Also Read: Savy Infra and Logistics shares gain 11.5% after securing mega work orders worth ₹923 Cr

Shareholding pattern of Granules India

Particulars	Feb 2026	Dec 2025	Sep 2025
Promoter	38.00%	38.80%	38.80%
FII	13.80%	13.60%	14.10%
DII	18.50%	17.50%	17.90%
Public	29.70%	30.20%	29.20%

About Granules India

Granules India Ltd (NSE: GRANULES) manufactures and sells Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and Finished Dosages through its subsidiaries, serving domestic and international pharmaceutical markets.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs